id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0599-0043,FDA,FDA-2011-N-0599,"Allergy Laboratories, Inc., Opportunity for Hearing on Proposal To Revoke
U.S.; License No. 103",Notice,General Notice,2014-04-30T04:00:00Z,2014,4,2014-04-30T04:00:00Z,2014-07-01T03:59:59Z,2014-04-30T13:49:32Z,2014-09771,0,0,09000064816d6c26
FDA-2011-N-0599-0040,FDA,FDA-2011-N-0599,"Letter from Allergy Laboratories, Inc to FDA CBER",Other,Letter(s),2014-04-28T04:00:00Z,2014,4,2014-04-28T04:00:00Z,,2014-04-28T17:06:56Z,,0,0,09000064816d1f3a
FDA-2011-N-0599-0042,FDA,FDA-2011-N-0599,"Letter from  FDA/CBER to Allergy Laboratories, Inc",Other,Letter(s),2014-04-28T04:00:00Z,2014,4,2014-04-28T04:00:00Z,,2014-04-28T17:16:16Z,,0,0,09000064816d21b3
FDA-2011-N-0599-0041,FDA,FDA-2011-N-0599,"Letter from Allergy Laboratories, Inc to FDA CBER",Other,Letter(s),2014-04-28T04:00:00Z,2014,4,2014-04-28T04:00:00Z,,2014-04-28T17:11:46Z,,0,0,09000064816d21b1